H. Yun

发表

Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.

D. Collier, J. Curtis, V. Schabert, 2014, Clinical therapeutics.

Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data

K. Saag, M. Morrisey, J. Curtis, 2009, Osteoporosis International.

Health Care Expenditures Associated With Skeletal Fractures Among Medicare Beneficiaries, 1999–2005

K. Saag, M. Morrisey, J. Curtis, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States

Christie M. Bartels, L. Fraenkel, M. Safford, 2019, Arthritis care & research.

Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 through 2009-2010.

T. Brown, M. Farkouh, S. Glasser, 2013, The American journal of cardiology.

Statin Use Following Hospitalization Among Medicare Beneficiaries With a Secondary Discharge Diagnosis of Acute Myocardial Infarction

T. Brown, M. Farkouh, P. Muntner, 2015, Journal of the American Heart Association.

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient‐Reported Outcome Data Collection: A Qualitative Study

L. Fraenkel, J. Willig, M. Danila, 2018, Arthritis care & research.

The Effects of the Balanced Budget Act of 1997 on Home Health and Hospice in Older Adult Cancer Patients

C. Ritchie, J. Locher, D. Grabowski, 2009, Medical care.

Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available

J. Curtis, H. Yun, F. Xie, 2020, Arthritis Research & Therapy.

Inpatient Diagnosis of Delirium and Encephalopathy: Coding Trends 2011-2018

Jeffrey A. Franks, E. Bowman, H. Yun, 2022, Journal of the Academy of Consultation-Liaison Psychiatry.

Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry

K. Michaud, J. Yazdany, G. Schmajuk, 2021, Rheumatology International.

Use of Oral and Subcutaneous Methotrexate in Rheumatoid Arthritis Patients in the United States

C. Spettell, K. Saag, J. Curtis, 2014, Arthritis care & research.

ISPE‐Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID‐19: Opportunities and Trade‐Offs

C. Yanover, C. Rentsch, D. Moga, 2022, Clinical pharmacology and therapeutics.

’ s response to reviews Title : Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis ?

Andrea L. Cherrington, H. Yun, M. Morris, 2019 .

Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn's Disease.

Frank I. Scott, C. Brensinger, J. Roy, 2018, Inflammatory bowel diseases.

Improved Quality of Life With Anti-TNF Therapy Compared With Continued Corticosteroid Utilization in Crohn’s Disease

Frank I. Scott, C. Brensinger, J. Roy, 2017 .

Generic alendronate use among medicare beneficiaries: are part d data complete?

P. Muntner, K. Saag, M. Morrisey, 2013, Pharmacoepidemiology and drug safety.

Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data

K. Saag, J. Curtis, E. Delzell, 2012, Arthritis care & research.

Trends in the Prevalence, Awareness, Treatment and Control of High Low Density Lipoprotein-Cholesterol among US Adults from 1999–2000 through 2009–2010

Bittner, T. Brown, P. Muntner, 2013 .

Does Cholecystectomy Prior to the Diagnosis of Pancreatic Cancer Affect Outcome?

M. Hawn, H. Yun, S. Gray, 2008, The American surgeon.

Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis

J. Singh, J. Lewis, P. Muntner, 2016, Annals of the rheumatic diseases.

Identifying newly approved medications in Medicare claims data: a case study using tocilizumab

J. Lewis, J. Curtis, E. Delzell, 2013, Pharmacoepidemiology and drug safety.

LDL cholesterol response and statin adherence among high-risk patients initiating treatment.

M. Farkouh, P. Muntner, M. Safford, 2016, The American journal of managed care.

Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower® Registry

J. Curtis, H. Yun, G. Kricorian, 2021, Rheumatology and Therapy.

Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination

J. Singh, J. Baddley, K. Saag, 2016, Arthritis & rheumatology.

Herpes Zoster and the Risk of Stroke in Patients With Autoimmune Diseases

J. Baddley, J. Curtis, K. Winthrop, 2017, Arthritis & rheumatology.

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease‐Modifying Therapy

J. Lewis, J. Baddley, K. Saag, 2015, Arthritis care & research.

Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program

J. Lewis, K. Saag, J. Curtis, 2013, Arthritis care & research.

Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs - Analysis of a national claims database.

J. Curtis, H. Yun, M. Rajan, 2022, Seminars in arthritis and rheumatism.

Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart

M. Danila, K. Saag, J. Curtis, 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare population

K. Saag, J. Curtis, E. Delzell, 2012, Arthritis care & research.

Linkage of a De‐Identified United States Rheumatoid Arthritis Registry With Administrative Data to Facilitate Comparative Effectiveness Research

Jeffrey R Curtis, Daniel H Solomon, Soko Setoguchi, 2014, Arthritis care & research.

Adherence patterns in naïve and prevalent use of infliximab and its biosimilar

J. Curtis, H. Yun, S. Bernatsky, 2022, BMC Rheumatology.

Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis

D. Collier, J. Curtis, V. Schabert, 2014, Journal of medical economics.

J. Curtis, K. Winthrop, H. Yun, 2015 .

Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis

J. Beaumont, D. Cella, J. Curtis, 2021, The Journal of Rheumatology.

Risk for Herpes Zoster in Tofacitinib‐Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids

J. Curtis, K. Winthrop, H. Yun, 2019, Arthritis care & research.

Central DXA utilization shifts from office‐based to hospital‐based settings among medicare beneficiaries in the wake of reimbursement changes

K. Saag, M. Morrisey, J. Curtis, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Predicting hip and major osteoporotic fractures using administrative data.

K. Ensrud, M. Morrisey, J. Curtis, 2010, Archives of internal medicine.

Death, debility, and destitution following hip fracture.

Jeffrey R Curtis, Kenneth G Saag, Michael A Morrisey, 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis

J. Curtis, K. Winthrop, H. Yun, 2016, Annals of the rheumatic diseases.

SAT0370 TUMOUR NECROSIS FACTOR INHIBITOR THERAPY DOES NOT REDUCE THE INCIDENCE OF COMORBIDITIES AND EXTRA-ARTICULAR MANIFESTATIONS IN ANKYLOSING SPONDYLITIS: AN ANALYSIS OF THREE US CLAIMS DATABASES

A. Deodhar, J. Curtis, K. Winthrop, 2020, Annals of the Rheumatic Diseases.

Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.

D. Margolis, C. Brensinger, J. Lewis, 2016, JAMA dermatology.

P. Muntner, K. Saag, J. Curtis, 2017, Annals of the rheumatic diseases.

Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare

J. Lewis, J. Baddley, K. Saag, 2015, Arthritis & rheumatology.

Risk of Hospitalized Infection Among Rheumatoid Arthritis Patients Concurrently Treated With a Biologic Agent and Denosumab

K. Saag, J. Curtis, E. Delzell, 2015, Arthritis & rheumatology.

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy

J. Lewis, J. Baddley, K. Saag, 2014, Annals of the rheumatic diseases.

Physician supply, treatment, and amputation rates for peripheral arterial disease.

J. Allison, D. Wirthlin, H. Yun, 2005, Journal of vascular surgery.

Recent trends in hip fracture rates by race/ethnicity among older US adults

K. Saag, M. Morrisey, J. Curtis, 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Human Papillomavirus Vaccination Schedule: Adherence Among Commercially Insured Adolescents and Young Adults in the United States, 2011-2017.

E. Levitan, S. Shrestha, H. Yun, 2020, American journal of public health.

Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.

T. Brown, M. Farkouh, P. Muntner, 2015, Journal of the American College of Cardiology.

Impact of Biologic Agents With and Without Concomitant Methotrexate and at Reduced Doses in Older Rheumatoid Arthritis Patients

K. Saag, J. Curtis, E. Delzell, 2015, Arthritis care & research.

Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty

J. Baker, J. Curtis, H. Yun, 2017, Arthritis care & research.

Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease

C. Brensinger, J. Roy, J. Lewis, 2018, The American Journal of Gastroenterology.

An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data

G. Burmester, P. Biswas, R. Rojo, 2020, Drug Safety.

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases

R. Suruki, A. Deodhar, J. Curtis, 2021, ACR open rheumatology.

Identifying types of nursing facility stays using medicare claims data: an algorithm and validation

K. Saag, J. Locher, M. Morrisey, 2010, Health Services and Outcomes Research Methodology.

Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis

J. Baker, J. Curtis, K. Winthrop, 2020, Annals of Internal Medicine.

Trends in Hospital and Surgeon Volume and Operative Mortality for Cancer Surgery

M. Heslin, H. Yun, V. Ho, 2006, Annals of Surgical Oncology.

Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long‐Term Use of Glucocorticoids

J. Baker, J. Curtis, H. Yun, 2020, Arthritis care & research.

Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn’s Disease Patients

H. Yun, F. Xie, T. Malik, 2018, Scientific Reports.

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

J. Kremer, J. Greenberg, M. Hauben, 2020, Annals of the Rheumatic Diseases.

Association of Anti–Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease

Wyndy Wiitala, J. Lewis, Tony Van, 2021, JAMA network open.

Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center

H. Yun, F. Xie, T. Malik, 2018, Gastroenterology research.

Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn’s Disease Patients

H. Yun, F. Xie, T. Malik, 2018, Scientific Reports.

Minor, Major, Low-Trauma, and High-Trauma Fractures: What Are the Subsequent Fracture Risks and How Do They Vary?

N. Patkar, E. Delzell, H. Yun, 2011, Current osteoporosis reports.

Benefits of Methotrexate Use on Cardiovascular Disease Risk Among Rheumatoid Arthritis Patients Initiating Biologic Disease-modifying Antirheumatic Drugs

E. Levitan, J. Curtis, H. Yun, 2020, The Journal of Rheumatology.

Evaluation of the Effect of Diabetes on Rheumatoid Arthritis–related Outcomes in an Electronic Health Record–based Rheumatology Registry

J. Curtis, H. Yun, Lang Chen, 2020, The Journal of Rheumatology.

Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents

M. Danila, J. Curtis, K. Winthrop, 2016, Journal of psoriasis and psoriatic arthritis.

Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients

P. Muntner, E. Levitan, J. Curtis, 2019, Arthritis care & research.

Is Rheumatoid Arthritis a Cardiovascular Risk‐Equivalent to Diabetes Mellitus?

J. Singh, P. Muntner, M. Safford, 2018, Arthritis care & research.

Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes.

T. Brown, M. Farkouh, G. Howard, 2014, Annals of epidemiology.

Awareness, Treatment, and Control of LDL Cholesterol Are Lower Among U.S. Adults With Undiagnosed Diabetes Versus Diagnosed Diabetes

T. Brown, M. Farkouh, S. Glasser, 2013, Diabetes Care.

Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study

J. Singh, J. Curtis, H. Yun, 2017, Arthritis Research & Therapy.

Influence of Multimorbidity on New Treatment Initiation and Achieving Target Disease Activity Thresholds in Active Rheumatoid Arthritis: A Cohort Study Using the Rheumatology Informatics System for Effectiveness Registry

K. Michaud, T. Mikuls, J. Curtis, 2021, Arthritis care & research.

Risk for Herpes Zoster in Tofacitinib‐Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids

J. Curtis, K. Winthrop, H. Yun, 2019, Arthritis Care & Research.

Health services utilization after fractures: evidence from Medicare.

K. Saag, M. Morrisey, J. Curtis, 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments

S. Bernatsky, J. Curtis, H. Yun, 2016, Arthritis & rheumatology.

Assessing Rheumatoid Arthritis Disease Activity With Patient‐Reported Outcomes Measurement Information System Measures Using Digital Technology

J. Curtis, H. Yun, Lang Chen, 2020 .

Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States

Theresa L. Ford, J. Curtis, H. Yun, 2023, ACR open rheumatology.

The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights

J. Kremer, J. Greenberg, L. Harrold, 2017, Pharmacoepidemiology and drug safety.

Fractures and mortality in relation to different osteoporosis treatments.

C. O'connor, P. Muntner, K. Saag, 2015, Clinical and experimental rheumatology.

Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries

P. Muntner, K. Saag, M. Morrisey, 2014, BMC Musculoskeletal Disorders.

Accuracy of Medicare Claim–based Algorithm to Detect Breast, Prostate, or Lung Cancer Bone Metastases

N. Sathiakumar, C. Falkson, E. Delzell, 2017, Medical care.

Factors associated with breast cancer screening behaviors in a sample of Jamaican women in 2013

Byron C. Jaeger, H. Yun, P. Jolly, 2020, Women & health.

Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease

M. Farkouh, S. Glasser, P. Muntner, 2014, The American journal of the medical sciences.

Clinical and demographic factors associated with fractures among older Americans

K. Saag, M. Morrisey, J. Curtis, 2011, Osteoporosis International.

Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System

K. Saag, M. Morrisey, J. Curtis, 2013, Arthritis care & research.

Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk

K. Saag, J. Curtis, E. Delzell, 2020, Medical care.

The comparative effectiveness of biologics among older adults and disabled rheumatoid arthritis patients in the Medicare population.

K. Saag, J. Curtis, E. Delzell, 2015, British journal of clinical pharmacology.

Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population.

D. Collier, J. Curtis, D. Harrison, 2015, Journal of managed care & specialty pharmacy.

Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study

C. Brensinger, A. Clark, J. Curtis, 2016, Arthritis & rheumatology.

Potential and Pitfalls of Using Large Administrative Claims Data to Study the Safety of Osteoporosis Therapies

K. Saag, E. Delzell, H. Yun, 2011, Current rheumatology reports.

Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis

K. Saag, J. Curtis, H. Yun, 2016, Arthritis care & research.

Race and Non-Hodgkin’s Lymphoma: Adverse Impact of Race and Treatment Delays on Survival. A SEER-Medicare Population Study (1995–2003).

L. Gary, H. Yun, M. Kilgore, 2007 .

Trends in the Utilization and Outcomes of Medicare Patients Hospitalized for Hip Fracture, 2000-2008

K. Saag, M. Morrisey, J. Curtis, 2014, Journal of aging and health.

Awareness, Treatment, and Control of LDLCholesterolAre LowerAmongUnited States AdultsWith Undiagnosed Diabetes Versus Diagnosed Diabetes

Stephen, Michael, Ľ., 2013 .

New methods for determining comparative effectiveness in rheumatoid arthritis

J. Curtis, H. Yun, 2013, Current opinion in rheumatology.

Further evaluation of a claims-based algorithm to determine the effectiveness of biologics for rheumatoid arthritis using commercial claims data

D. Collier, J. Curtis, D. Harrison, 2013, Arthritis Research & Therapy.

Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database With Tofacitinib Trial Data

M. Regueiro, J. Cappelleri, G. Chan, 2020, Inflammatory bowel diseases.

Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites

T. Akinyemiju, M. Pisu, H. Yun, 2017, Journal of Ovarian Research.

Comparative Infectious Risk of Immunosuppressive Therapies Used in Psoriasis

J. Baddley, J. Curtis, K. Winthrop, 2016 .

Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.

M. Farkouh, P. Muntner, M. Safford, 2014, The American journal of cardiology.

Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat‐to‐Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology

J. Curtis, H. Yun, Lang Chen, 2020 .

ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry

J. Stone, Hyon K. Choi, J. Curtis, 2021, The Journal of Rheumatology.

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

A. Praestgaard, J. Curtis, H. Yun, 2023, Rheumatology and Therapy.

Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?

L. Fraenkel, J. Willig, Andrea L. Cherrington, 2019, BMC Rheumatology.

J. Curtis, H. Yun, Lang Chen, 2018, Arthritis & rheumatology.

J. Curtis, H. Yun, Lang Chen, 2020, Arthritis care & research.

Patient Valued Comparative Effectiveness of Corticosteroids versus Anti-TNF Alpha Therapy for Inflammatory Bowel Disease

C. Brensinger, J. Roy, F. Johnson, 2018 .

Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States

K. Saag, J. Curtis, S. Kertesz, 2017, Arthritis & rheumatology.

Secondary analysis of merged American Hospital Association data and U.S. Census data: beginning to understand the supply-demand chain in pediatric inpatient care.

J. Allison, R. Hughes, H. Yun, 2008, Journal of pediatric nursing.

Minimally Important Differences for Patient-Reported Outcomes Measurement Information System (Promis) Fatigue and Pain Interference Scores

J. Fries, J. Beaumont, D. Cella, 2015 .

Adaptation of Bayesian Data Mining Algorithms to Longitudinal Claims Data: Coxib Safety as an Example

Jeffrey R Curtis, Meredith Kilgore, David Fram, 2008, Medical care.

Use of Medicare Claims Data for the Identification of Myocardial Infarction: The Reasons for Geographic And Racial Differences in Stroke Study

G. Howard, P. Muntner, M. Safford, 2018, Medical care.